Arthur Lahr, co-founder and CEO. Mr Lahr holds a Masters degree in applied physics from the University of Delft in the Netherlands, and an MBA from INSEAD, France. Previously, Arthur was CEO of Kiadis Pharma, a clinical stage biopharmaceutical company, developing next generation cell therapies, that was acquired by Sanofi in 2021. Prior to this he was Chief Strategy Officer and member of the management committee at Crucell from 2001 until its acquisition by Johnson and Johnson in 2011. Before that he was a consultant at McKinsey, and engineer at Unilever.